Rivastigmine
Who holds supplier records for Rivastigmine? 13 organisations hold a current record for Rivastigmine: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 9 of them hold a valid EU Certificate of Suitability (10 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (7), Sweden (1), Italy (1), Peru (1) and 2 other countries (2); not recorded for 1.
Most records are filed under another form of this substance: Rivastigmine Tartrate (19 current sources). A DMF or CEP is listed under the form it names.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Rivastigmine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/rivastigmine
Reading the evidence
- 13 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 8 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (13)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Rivastigmine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- MSN Organics Private LimitedIndiaCEPActive DMF 29133, 36529 · latest filing Jan 2022
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 29199 · latest filing Mar 2015
- CAMBREX KARLSKOGA ABSwedenCEP Company GMP cert on recordActive DMF 29826 · latest filing Sept 2015
- ERREGIERRE SPAItalyCEP Company GMP cert on recordActive DMF 25871 · latest filing Dec 2011
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 26499 · latest filing Sept 2012
- SHODHANA LABORATORIES LTDIndiaCEPActive DMF 40601 · latest filing Oct 2024
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 29519 · latest filing Jul 2015
- APOTEX PHARMACHEM INCActive DMF 29033 · latest filing Mar 2015
- INTERQUIM SAPeruCEP Company GMP cert on recordActive DMF 22974 · latest filing Jul 2009
- JUBILANT BIOSYS LTDIndiaActive DMF 24502 · latest filing Mar 2011
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 27516 · latest filing Sept 2013
- GermanyCEP Company GMP cert on record
- SlovakiaCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (10)
Certificates of Suitability on the EDQM register for Rivastigmine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 12 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| SHODHANA LABORATORIES PRIVATE LIMITED Visakhapatnam | IN | CEP 2026-204 - Rev 00 Rivastigmine, Vizag site | Oct 2026 | — |
| ERREGIERRE S.P.A. San Paolo D'Argon | IT | CEP 2025-073 - Rev 01 Rivastigmine | Aug 2026 | Inspected Nov 2025 Italy |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy | IN | CEP 2012-304 - Rev 04 Rivastigmine | Jul 2026 | — |
| AREVIPHARMA GMBH Radebeul | DE | CEP 2025-405 - Rev 00 Rivastigmine | Jul 2026 | Inspected Jun 2025 Germany |
| CAMBREX KARLSKOGA AB Karlskoga | SE | R1-CEP 2014-291 - Rev 01 Rivastigmine | May 2023 | — |
| SANECA PHARMACEUTICALS A.S. Hlohovec | SK | R1-CEP 2015-276 - Rev 00 Rivastigmine | Jan 2023 | — |
| MSN ORGANICS PRIVATE LIMITED Bibinagar Village | IN | R1-CEP 2015-279 - Rev 00 Rivastigmine | Sept 2022 | — |
| SHODHANA LABORATORIES PRIVATE LIMITED Hyderabad | IN | R1-CEP 2015-236 - Rev 00 Rivastigmine | Aug 2022 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | R1-CEP 2015-039 - Rev 00 Rivastigmine | Nov 2020 | — |
| Interquim, S.A. Sant Cugat Del Vallès | ES | R1-CEP 2013-354 - Rev 00 Rivastigmine | Jan 2020 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (2)
Organisations whose Type II DMFs for Rivastigmine are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- India · Inactive DMF 25910 · filed May 2012
- MYLAN LABORATORIES LTDInactive DMF 24485 · filed Dec 2010
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Rivastigmine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL636).
Chemical identity
- IUPAC name
- [3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate
- Canonical SMILES
- CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C
- InChIKey
- XSVMFMHYUFZWBK-NSHDSACASA-N
- Synonyms
- ENA-713, ENA-713D, Exelon, ONO-2540, Rivastigmina, Rivastigmine, Rivastigmine 3m health care ltd, SDZ-212-713, SDZ-212713, SDZ-ENA-713, Prometax, ENA 713 free base
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Cholinesterase Inhibitor
- Mechanism of action
- Cholinesterase Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Rivastigmine?
13 organisations hold an active US FDA Type II Drug Master File or a CEP for Rivastigmine: MSN Organics Private Limited (India), Alembic Pharmaceuticals Limited (India), CAMBREX KARLSKOGA AB (Sweden), ERREGIERRE SPA (Italy), MATRIX PHARMACORP PRIVATE LTD (India), SHODHANA LABORATORIES LTD (India), APITORIA PHARMA PRIVATE LTD (India) and APOTEX PHARMACHEM INC, and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Rivastigmine Drug Master Files are active?
MSN Organics Private Limited (DMF 29133, 36529), Alembic Pharmaceuticals Limited (DMF 29199), CAMBREX KARLSKOGA AB (DMF 29826), ERREGIERRE SPA (DMF 25871), MATRIX PHARMACORP PRIVATE LTD (DMF 26499), SHODHANA LABORATORIES LTD (DMF 40601), APITORIA PHARMA PRIVATE LTD (DMF 29519) and APOTEX PHARMACHEM INC (DMF 29033) and 3 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Rivastigmine records mean?
2 organisations have only inactive Type II DMFs for Rivastigmine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Rivastigmine have a European Certificate of Suitability?
Yes. 9 organisations hold a valid CEP for Rivastigmine on the EDQM register, including SHODHANA LABORATORIES PRIVATE LIMITED Visakhapatnam (IN), ERREGIERRE S.P.A. San Paolo D'Argon (IT), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), AREVIPHARMA GMBH Radebeul (DE), CAMBREX KARLSKOGA AB Karlskoga (SE) and SANECA PHARMACEUTICALS A.S. Hlohovec (SK) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Rivastigmine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Rivastigmine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.